Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Nanomedicine (London, England)|April 20, 2016
Nanoscale bioactive glass activates osteoclastic differentiation of RAW 264.7 cellsRainer Detsch, Matthias Rübner, Pamela L Strissel, et al.
Therapeutic Advances in Medical Oncology|December 16, 2024
Random forest algorithm identifies miRNA signatures for breast cancer detection and classification from patient urine samplesJochen Maurer, Matthias Rübner, Chao-Chung Kuo, et al.
Breast Cancer Research and Treatment|August 28, 2020
Impact of fibroblast growth factor receptor 1 (FGFR1) amplification on the prognosis of breast cancer patientsRamona Erber, Matthias Rübner, Simon Davenport, et al.
Cells|June 11, 2025
Prognostic Significance of Macrophage Phenotypes in Peri-Tumoral Normal Tissue of Early-Stage Breast CancerMarcel Hirschmann, Sören Schnellhardt, Matthias Rübner, et al.
Cancers|October 14, 2023
Clinical Characteristics and Prognosis of HER2-0 and HER2-Low-Positive Breast Cancer Patients: Real-World Data from Patients Treated with Neoadjuvant ChemotherapyPatrik Pöschke, Peter A Fasching, Werner Adler, et al.
Geburtshilfe Und Frauenheilkunde|November 11, 2020
HLA-J, a Non-Pseudogene as a New Prognostic Marker for Therapy Response and Survival in Breast CancerFranziska M Würfel, Ralph M Wirtz, Christoph Winterhalter, et al.
NPJ Precision Oncology|June 6, 2026
AI-assisted histomorphological stratification of endometrial cancer: real-world validation of foundation models for molecular subtypingLaura Schwarzmann, Robert Stöhr, Julius Emons, et al.
The Journal of Molecular Diagnostics : JMD|May 2, 2024
Quality-Assured Analysis of PIK3CA Mutations in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer TissueCarolin Schmidt, Robert Stöhr, Lora Dimitrova, et al.
Gynecologic Oncology|February 19, 2017
Genetic risk factors for ovarian cancer and their role for endometriosis riskStefanie Burghaus, Peter A Fasching, Lothar Häberle, et al.
Breast Cancer Research and Treatment|November 25, 2024
Impact of CCND1 amplification on the prognosis of hormone receptor-positive, HER2-negative breast cancer patients-correlation of clinical and pathological markersDorothea Hanf, Peter Fasching, Paul Gass, et al.
Pageof 4